Home › Funds › NATIXIS ADVISORS, LLC › MRK

NATIXIS ADVISORS, LLC position in MRK

MERCK & CO INC · Health Care

NATIXIS ADVISORS, LLC reported holding 2,988,407 shares of MRK (MERCK & CO INC) in its Q3 2026 13F filing — a position valued at US$434.2M, representing 0.46% of its reported portfolio and ranking #31 among its reported holdings. NATIXIS ADVISORS, LLC has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.99M sh
Reported value held$434.25M
Portfolio Weight0.46%
First reportedQ3 2023
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How NATIXIS ADVISORS, LLC's MRK position evolved

NATIXIS ADVISORS, LLC first disclosed a stake in MRK in Q3 2023 at 1,176,543 shares (US$121.1M). The position peaked in Q3 2026 at 2,988,407 shares, worth US$434.2M. Across 13 filings, NATIXIS ADVISORS, LLC increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,988,407 shares valued at US$434.2M — an increase of 130,779 shares quarter over quarter.. Notable position changes include a 33% increase in Q4 2024 (shares fell 9% over the following quarter), a 32% increase in Q2 2025 (shares rose 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.18M $121.12M New
Q4 2023 1.21M $131.59M Add
Q1 2024 1.28M $168.31M Add
Q2 2024 1.36M $167.90M Add
Q3 2024 1.23M $139.89M Reduce
Q4 2024 1.64M $163.07M Add
Q1 2025 1.46M $131.38M Reduce
Q2 2025 1.94M $153.51M Add
Q3 2025 2.31M $193.90M Add
Q4 2025 2.53M $266.05M Add
Q1 2026 2.97M $357.30M Add
Q2 2026 2.86M $367.20M Reduce
Q3 2026 2.99M $434.25M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRK and 13F data

MRK (MERCK & CO INC) is a Health Care company. 30 other funds we track also report a position in MRK — the largest reported positions include BlackRock Inc (US$33.14B), Vanguard Group (US$26.77B), VANGUARD CAPITAL MANAGEMENT LLC (US$23.47B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRK

All MRK fund holders →

FAQ

How long has NATIXIS ADVISORS, LLC held MRK?

NATIXIS ADVISORS, LLC has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is NATIXIS ADVISORS, LLC's current position in MRK?

As of Q3 2026, NATIXIS ADVISORS, LLC holds 2.99M shares of MRK (MERCK & CO INC), valued at $434.25M, representing 0.46% of its reported portfolio and ranking #31.

Has NATIXIS ADVISORS, LLC been buying or selling MRK?

In the latest 13F filing (Q3 2026), NATIXIS ADVISORS, LLC increased its position in MRK. The position peaked in Q3 2026 at 2.99M shares.

Which other funds hold MRK?

Other major institutional holders of MRK include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.